(Total Views: 158)
Posted On: 10/11/2025 10:28:07 PM
Post# of 8732
Electrome + Viant + BIEL = $$$
1. Technology Licensing Agreement
Structure: BIEL licenses its Pulsed Shortwave Therapy (PSWT) technology (used in ActiPatch and RecoveryRx) to Electrome.
Benefits:
Electrome gains access to clinically validated tech without reinventing the wheel.
BIEL monetizes its IP and expands its market reach.
Koneru’s/Viant Role: Facilitates technical integration and ensures regulatory alignment.
2. Joint Development of a New Device
Structure: Co-development of a next-gen wearable or implantable neuromodulation device.
Focus Areas:
Chronic pain
Post-operative recovery
Mental health (e.g., anxiety, depression via vagus nerve stimulation)
Koneru’s/Viant Role: Leads clinical trial design and FDA strategy, leveraging his prior success with ActiPatch approvals.
3. Contract Manufacturing & Scale-Up
Structure: Electrome uses Koneru’s current firm (Viant) for manufacturing BIEL’s devices or new joint products.
Benefits:
Rapid scale-up using existing infrastructure.
Quality assurance from a team familiar with BIEL’s standards.
Koneru’s/Viant Role: Oversees production and ensures compliance with CE/FDA standards.
4. Clinical Research Collaboration
Structure: Electrome and BIEL co-sponsor clinical trials to validate new applications of PSWT or hybrid technologies.
Potential Studies:
Comparative effectiveness vs. TENS or other electroceuticals.
Long-term outcomes in central sensitization disorders.
Koneru’s Role: Designs protocols and co-authors publications, enhancing credibility.
5. Strategic Investment or Acquisition
Structure: Electrome invests in or acquires BIEL to consolidate IP and talent.
Rationale:
BIEL’s regulatory groundwork and product portfolio complement Electrome’s ambitions.
Koneru’s dual involvement could ease integration.
Koneru’s Role: Acts as a bridge between leadership teams and aligns technical roadmaps.
6. White-Labeling or OEM Partnership
Structure: Electrome rebrands BIEL’s devices for specific markets (e.g., sports recovery, military use, telehealth).
Benefits:
Faster market entry for Electrome.
BIEL expands distribution without direct overhead.
Koneru’sViant Role: Customizes device specs and ensures branding compliance.
1. Technology Licensing Agreement
Structure: BIEL licenses its Pulsed Shortwave Therapy (PSWT) technology (used in ActiPatch and RecoveryRx) to Electrome.
Benefits:
Electrome gains access to clinically validated tech without reinventing the wheel.
BIEL monetizes its IP and expands its market reach.
Koneru’s/Viant Role: Facilitates technical integration and ensures regulatory alignment.
2. Joint Development of a New Device
Structure: Co-development of a next-gen wearable or implantable neuromodulation device.
Focus Areas:
Chronic pain
Post-operative recovery
Mental health (e.g., anxiety, depression via vagus nerve stimulation)
Koneru’s/Viant Role: Leads clinical trial design and FDA strategy, leveraging his prior success with ActiPatch approvals.
3. Contract Manufacturing & Scale-Up
Structure: Electrome uses Koneru’s current firm (Viant) for manufacturing BIEL’s devices or new joint products.
Benefits:
Rapid scale-up using existing infrastructure.
Quality assurance from a team familiar with BIEL’s standards.
Koneru’s/Viant Role: Oversees production and ensures compliance with CE/FDA standards.
4. Clinical Research Collaboration
Structure: Electrome and BIEL co-sponsor clinical trials to validate new applications of PSWT or hybrid technologies.
Potential Studies:
Comparative effectiveness vs. TENS or other electroceuticals.
Long-term outcomes in central sensitization disorders.
Koneru’s Role: Designs protocols and co-authors publications, enhancing credibility.
5. Strategic Investment or Acquisition
Structure: Electrome invests in or acquires BIEL to consolidate IP and talent.
Rationale:
BIEL’s regulatory groundwork and product portfolio complement Electrome’s ambitions.
Koneru’s dual involvement could ease integration.
Koneru’s Role: Acts as a bridge between leadership teams and aligns technical roadmaps.
6. White-Labeling or OEM Partnership
Structure: Electrome rebrands BIEL’s devices for specific markets (e.g., sports recovery, military use, telehealth).
Benefits:
Faster market entry for Electrome.
BIEL expands distribution without direct overhead.
Koneru’sViant Role: Customizes device specs and ensures branding compliance.
(3)
(0)
